Targeting the KCa3.1 channel suppresses diabetes-associated atherosclerosis via the STAT3/CD36 axis.
Jiang XX, Bian W, Zhu YR, Wang Z, Ye P, Gu Y, Zhang H, Zuo G, Li X, Zhu L, Liu Z, Sun C, Chen SL, Zhang DM.
Jiang XX, et al. Among authors: ye p.
Diabetes Res Clin Pract. 2022 Mar;185:109776. doi: 10.1016/j.diabres.2022.109776. Epub 2022 Feb 9.
Diabetes Res Clin Pract. 2022.
PMID: 35149165